| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
127,470,000 |
| Market
Cap: |
1.66(B) |
| Last
Volume: |
878,666 |
Avg
Vol: |
1,074,261 |
| 52
Week Range: |
$11.665 - $20.73 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
1,049 |
9,748 |
12,417 |
12,417 |
| Total Sell Value |
$16,511 |
$152,803 |
$201,886 |
$201,886 |
| Total People Sold |
1 |
2 |
2 |
2 |
| Total Sell Transactions |
1 |
3 |
4 |
4 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tetrault Lynn A. |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,564 |
37,346 |
|
- |
|
| Hipp Raymond R |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,564 |
287,580 |
|
- |
|
| Jones Steven C |
Executive Vice President |
• • – |
2018-05-31 |
4 |
S |
$11.68 |
$204,961 |
I/I |
(17,548) |
2,980,533 |
|
- |
|
| Jones Steven C |
Executive Vice President |
• • – |
2018-05-30 |
4 |
S |
$11.72 |
$440,895 |
I/I |
(37,619) |
2,998,081 |
|
- |
|
| Jones Steven C |
Executive Vice President |
• • – |
2018-05-29 |
4 |
S |
$11.67 |
$1,333,881 |
I/I |
(114,300) |
3,035,700 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-05-29 |
4 |
S |
$11.62 |
$758,100 |
D/D |
(65,000) |
13,322 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-05-29 |
4 |
OE |
$4.78 |
$310,700 |
D/D |
65,000 |
78,322 |
|
- |
|
| Cardoza George |
President, Pharma Services |
• – – |
2018-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
197,422 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2018-05-25 |
4 |
D |
$11.57 |
$43,098 |
D/D |
(3,725) |
19,491 |
|
- |
|
| Shovlin Robert J. |
President, Clinical Services |
• – – |
2018-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,666 |
23,216 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,666 |
6,666 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• – – |
2018-05-25 |
4 |
D |
$11.57 |
$253,429 |
D/D |
(21,904) |
1,876,761 |
|
- |
|
| Van Oort Douglas M |
Chairman and CEO |
• – – |
2018-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
65,680 |
1,898,665 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-05-15 |
4 |
S |
$11.21 |
$146,055 |
D/D |
(13,000) |
0 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-05-15 |
4 |
OE |
$4.78 |
$62,140 |
D/D |
13,000 |
13,000 |
|
- |
|
| Ross Steven A |
CIO |
• – – |
2018-05-10 |
4 |
S |
$10.78 |
$883,949 |
D/D |
(81,999) |
4,500 |
|
- |
|
| Ross Steven A |
CIO |
• – – |
2018-05-10 |
4 |
OE |
$4.78 |
$514,518 |
D/D |
81,999 |
86,499 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-03-28 |
4 |
D |
$8.20 |
$57,400 |
D/D |
(7,000) |
0 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2018-03-28 |
4 |
OE |
$4.78 |
$33,460 |
D/D |
7,000 |
7,000 |
|
- |
|
| Jones Steven C |
Executive Vice President |
• – – |
2017-12-14 |
4 |
GD |
$9.06 |
$181,200 |
D/D |
20,000 |
226,251 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2017-08-24 |
4 |
D |
$9.38 |
$211,050 |
D/D |
(22,500) |
0 |
|
- |
|
| Balliet Jennifer |
VP and Chief Culture Officer |
• – – |
2017-08-24 |
4 |
OE |
$3.45 |
$79,950 |
D/D |
22,500 |
22,500 |
|
- |
|
| Hannah Alison L. |
Director |
– • – |
2017-08-09 |
4 |
OE |
$6.66 |
$44,402 |
D/D |
6,667 |
45,449 |
|
- |
|
| Hannah Alison L. |
Director |
– • – |
2017-07-27 |
4 |
B |
$9.19 |
$183,800 |
D/D |
20,000 |
38,782 |
2.39 |
- |
|
| Brodie Steven G. |
Vice President of Operations |
• – – |
2017-07-05 |
4 |
OE |
$3.45 |
$22,998 |
D/D |
6,666 |
32,619 |
|
- |
|
544 Records found
|
|
Page 14 of 22 |
|
|
0.12 (0.91%) 
